Japan Vietnam Medical Instrument JSC

Japan Vietnam Medical Instrument JSC

JVC · VN · Healthcare / Medical Devices

2,550.00VND-20.00 (-0.78%)

Price History

Full chart

Market Stats

Previous Close2,570.00
Open2,570.00
Day Range2,500.00 – 2,570.00
52-Week Range2,400.00 – 9,100.00
Volume143.10K
Market Cap290.25B
P/E (TTM)0.00
Forward P/E0.00
EPS-59.08
Dividend Yield0.00%
Beta0.74
50-Day Avg2,896.60
200-Day Avg4,110.00

About

Japan Vietnam Medical Investment and Development Joint Stock Company engages in the distribution of medical equipment and instruments in Vietnam. The company distributes medical equipment, including diagnostic imaging products, such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray system, computed and direct radiography, dry imager, contrast injector, PET/CT imaging system, and diagnostic ultrasound products; washers, dryers, and sterilizers; and ultrasound systems, anesthesia and breathing machines, syringe and infusion pumps, and patient monitors, as well as navigation products. It also offers SD-S, DI-HT, SD-Q, and DI-HL dry medical films; central venous catheters and invasive blood pressure transducers for resuscitation-cardiovascular intervention; Scepter XC and C balloon, and Chaperon guiding catheters; LVIS Jr. and LVIS coil assist stents; and V-grip detachment controllers, Traxcess guidewires, Headway Duo microcatheters, ERIC retrieval devices, SOFIA PLUS aspiration and SOFIA intermediate catheters, FRED and FRED Jr. flow diversion devices, platinum and hydrogel coils, PHIL liquid embolics, and Headway microcatheters. In addition, the company provides technical services, such as consulting, technical support, repair, and maintenance services; and IT services for hospitals. Further, it leases medical equipment and instruments; operates general, specialist, and dental clinics; invests in medical equipment; and engages in the financial investment activities. Japan Vietnam Medical Investment and Development Joint Stock Company was formerly known as Vietnam Medical and Pharmaceutical Investment Joint Stock Company and changed its name to Japan Vietnam Medical Investment and Development Joint Stock Company in November 2025. The company was founded in 2001 and is headquartered in Hanoi, Vietnam.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Toan Van Vu
  • Employees167
  • HeadquartersICON 4 Building, Hanoi, Vietnam, Vietnam
  • Websitehttps://ytevietnhat.com.vn

Leadership

  • Mr. Toan Van VuGeneral Director, Member of Management Board & Director
  • Mr. Cuong Ngoc NguyenChief Financial Officer
  • Mr. Nam Dai NguyenDeputy General Director & Member of Management Board
  • Ms. Lua Thi NguyenChief Accountant

Financials

Income Statement

Currency: VND2015-03-312016-03-312017-03-312020-03-312021-03-312022-03-31
Total Revenue---517.17B411.42B391.23B
Growth (%)-----20.45%-4.91%
Cost of Revenue---408.12B375.56B350.70B
Gross Profit---109.06B35.85B40.53B
Gross Margin---21.09%8.71%10.36%
Operating Expense---120.87B110.77B78.68B
Operating Income----11.82B-74.91B-38.15B
Operating Margin----2.28%-18.21%-9.75%
EBITDA---80.94B31.76B58.67B
EBITDA Margin---15.65%7.72%15.00%
Net Income---2.80B-76.69B-29.94B
Net Income Margin---0.54%-18.64%-7.65%
Interest Expense---9.04M1.21B4.32B
Interest Expense % of Total Revenue---0.00%0.30%1.10%

Balance Sheet

Currency: VND2015-03-312016-03-312017-03-312020-03-312021-03-312022-03-31
Total Assets---637.86B627.73B600.53B
Total Liabilities---106.48B173.03B175.55B
Total Equity---531.38B454.69B424.75B
Cash---40.37B120.32B132.66B

Cash Flow

Currency: VND2015-03-312016-03-312017-03-312020-03-312021-03-312022-03-31
Operating Cash Flow2.61B-319.02B76.13B30.71B127.02B42.10B
Investing Cash Flow8.10B177.66B-38.62B---
Financing Cash Flow436.07B-346.36B-15.89B---
Capital Expenditure52.56B8.81B42.59B22.45B40.81B31.38B
Free Cash Flow---8.25B86.21B10.73B
Dividends Paid27.74B-----
FCF to OCF---26.87%67.87%25.48%

Earnings

Report DateMar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Mar 31, 2016Aug 31, 2016Nov 30, 2016Mar 1, 2017May 31, 2017Aug 30, 2017Nov 29, 2017Feb 28, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021Sep 1, 2021Dec 1, 2021Mar 2, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023May 31, 2023Aug 30, 2023Nov 29, 2023Feb 28, 2024May 29, 2024Aug 28, 2024Nov 27, 2024Feb 26, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------
EPS Actual81.2429.681234.822305.77124.66122.70183.40271.23533.2033.79-5791.71243.89-892.04-45.08-13.254.5034.3717.1623.769.2848.465.0312.9383.966.0723.819.9367.24-5.76-6.46-3.55-480.91-3.23-19.63-1.4727.4393.37-23.6651.51105.3780.94176.5160.5382.4174.98248.24217.2527.58109.2387.66100.94150.44
Surprise----------------------------------------------------
Timing----------------------------------------------------

Key Statistics & Ratios

Market Cap290.25B
Enterprise Value295.27B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.39
Price / Book0.90
EPS-59.08
Book Value5,487.81
Revenue (TTM)747.22B
Gross Profit (TTM)165.32B
EBITDA86.62B
Profit Margin6.76%
Operating Margin14.77%
Return on Equity8.14%
Return on Assets4.10%
Shares Outstanding112.50M
Shares Float95.50M
Beta0.74
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20141×
482.28Aug 7, 2014
20121×
1303.91Jan 5, 2012

Stock Splits

  • Oct 31, 2014536:517
  • Aug 7, 201411:10
  • Oct 8, 201323:20
  • Feb 6, 2013824:775
  • Jun 27, 201211:10